FJFang Jin

Fang Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fang Jin has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Chenghao Chen

    Beijing Children’s Hospital, Capital Medical University

    46 shared publications
  • Haiyan Cheng

    Department of Oncology Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, PR China

    46 shared publications
  • Huanmin Wang

    Department of Surgical Oncology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China

    46 shared publications
  • Hui Wang

    Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China

    46 shared publications
  • Jingang Gui

    Laboratory of Tumor Immunology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health , Beijing

    46 shared publications
  • Jun Feng

    Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China

    46 shared publications

Latest Publications

  • Open Access

    Supplementary Figure 11 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 11 Low-dose doxorubicin affects the expression of CD112 and CD155 in NB cells. (A) The apoptosis of SH-SY5Y and SK-N-BE2 cells treated with low-dose doxorubicin (0.1 μM) is detected by FACS (left) and AV+ proportion is labeled in the representative FACS histograms. (B-F) CD112 and CD155 expression in SH-SY5Y and SK-N-BE2 cells or primary NB tumor cells treated with low-dose doxorubicin (0.1 μM) are detected by FACS and Western blot. MFI is labeled in the representative FACS histograms. (G) and (H) The cytotoxicity assays are performed to detected γδT-cell cytotoxicity against SH-SY5Y and SK-N-BE2 cells pretreated with 0.1 μM doxorubicin. The results are expressed as the means ± SEMs from at least three independent experiments. Significant differences between groups are represented by * p < 0.05 and *** p < 0.001.

  • Open Access

    Supplementary Figure 10 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 10 Identification of Tet-on system, ROC curves and survival curves of different groups for NB tumor. (A) and (B) The variation of CD112 and CD155 expression in SK-N-BE2 cells treated with different concentration of doxycycline (0, 2 nM, 20 nM, 200 nM, 2 μM, 20 μM) is detected by qPCR and Western blot. (C) ROC curves are generated for CD112, CD155, and CD112/CD155 ratio to predict NB patient death, tumor risk or MYCN amplification. The results are expressed as the means ± SEMs from at least three independent experiments. Significant differences between groups are represented by ns no significance, * p < 0.05, ** p < 0.01 and *** p < 0.001.

  • Open Access

    Supplementary Figure 6 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 6 The cell-cycle scores and expression of functional genes in tumor cells and γδT cells in spatial transcriptome analysis and scRNA sequencing analysis. (A) Cell-cycle score analysis of tumor cells in spatial transcriptome analysis. (B) Spatial distribution and expression of proliferating markers. (C) Cell-cycle score analysis of tumor cells in scRNA sequencing analysis. (D) Violin plots showing the expression levels of neuroblastoma related genes in tumor cells in scRNA sequencing analysis. (E) and (F) Cell-cycle score and GSVA score analysis of γδT cells in scRNA sequencing analysis. (G) Violin plots showing the expression levels of DNAM-1, TIGIT, CD96, PD-1, TIM-3, IFN-γ, granzyme B and perforin in γδT cells in scRNA sequencing analysis.

  • Open Access

    Supplementary Figure 12 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 12 The effects of CD112 on γδT-cell-cytotoxicity against neuroblastoma, and on proliferation and migration of NB cells. (A-D) rhCD112 is used to treat γδT cells for 24 h. TIGIT, CD96 and CD112R are detected by FACS (left) or Western blot and MFI is labeled in the representative FACS histograms (right). (E) γδT-cell numbers are counted and statistically analyzed during in vitro culture in presence of rhCD112. (F) The CFSE proliferation assays are performed during in vitro culture in presence of rhCD112. γδT cells are detected by FACS (right) and statistically analyzed (left). MFI is labeled in the representative FACS histograms. (G) γδT cells are pre-treated with rhCD112 for 24 h and subjected to calcium flux detection by Fluo-4 AM labeling and low-concentration PMA and ionomycin stimulation. The calcium flux results are used to benchmark the levels of activation. The results are recorded and illustrated by FACS (right) and statistically analyzed (left). (H) The phosphorylation of Akt and ERK1/2 in γδT cells is detected by Western blot after treatment using rhCD112 with or without α-DNAM-1 for 24 h. (I) and (J) The cytotoxicity assays are performed with γδT cells pre-treated with rhCD112 for 24 h and NB cell lines. (K) and (L) The cytotoxicity assays are performed to detected γδT-cell cytotoxicity against SH-SY5Y and CHLA-255 cells in presence of α-CD112. (M-O) CCK-8, Transwell and wound-healing sassays are performed using CHLA-255-NC and CHLA-255-shCD112 cells. Representative images of CHLA-255 cell migration obtained from the Transwell (magnification × 100) and wound-healing (magnification × 100) assays are shown (right). The cell numbers obtained from the Transwell assays are counted, and the relative migration rate obtained from the wound-healing assays is calculated by dividing the change in the distance between the scratch edges by the initial distance (left). (P) CD112 is overexpressed in IMR-32 cells transiently by transfecting constructed CD112 vector and CD112 expression is detected by qPCR, FACS and Western blot. MFI is labeled in the representative FACS histograms. (Q) DNAM-1 reduction is detected by FACS after 24 h co-culture with IMR-32-vector or IMR-32-CD112 cells (left) and MFI is labeled in the representative FACS histograms (right). (R) The phosphorylation of Akt and ERK1/2 in γδT cells is detected by Western blot after CHLA-255-NC and CHLA-255-shCD112 stimulation. (S) The cytotoxicity assays are performed to detected γδT-cell cytotoxicity against IMR-32-vector and IMR-32-CD112 cells. The results are expressed as the means ± SEMs from at least three independent experiments. Significant differences between groups are represented by ns no significance, * p < 0.05, ** p < 0.01 and *** p < 0.001.

  • Open Access

    Supplementary Figure 1 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 1 Identified major cell types, cell proportion analysis and CD112 and CD155 expression in NB tumor scRNA-seq analysis. (A) Violin plots showing the number of features, RNA counts and percent mitochondrial transcripts following quality control. (B) Violin plots showing the average expression of the genes for annotating the major cell types identified in NB tumors. (C) UMAP plots showing the distribution of cell types for each sample. (D) Bar plots showing the proportions of cell types for each sample. (E) UMAP plots showing the expression levels of CD112 and CD155.

  • Open Access

    Supplementary Figure 13 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 13 The effects of CD155 on γδT-cell-cytotoxicity against neuroblastoma, and on proliferation and migration of NB cells. (A) and (B) α-TIGIT is used in the rhCD155 treatment of γδT cells. DNAM-1 is detected by FACS and Western blot. (C-F) rhCD155 is used to treat γδT cells for 24 h. TIGIT, CD96 and CD112R are detected by FACS (left) or Western blot and MFI is labeled in the representative FACS histograms (right). (G) γδT-cell numbers are counted and statistically analyzed during in vitro culture in presence of rhCD155. (H) The CFSE proliferation assays are performed during in vitro culture in presence of rhCD155. γδT cells are detected by FACS (right) and statistically analyzed (left). MFI is labeled in the representative FACS histograms. (I) γδT cells are pre-treated with rhCD155 for 24 h and subjected to calcium flux detection by Fluo-4 AM labeling and low-concentration PMA and ionomycin stimulation. The calcium flux results are used to benchmark the levels of activation. The results are recorded and illustrated by FACS (right) and statistically analyzed (left). (J) The phosphorylation of Akt and ERK1/2 in γδT cells is detected by Western blot after treatment using rhCD155 for 24 h. (K) and (L) The cytotoxicity assays are performed with γδT cells pre-treated with rhCD155 or α-TIGIT for 24 h and NB cell lines. (M) and (N) The cytotoxicity assays are performed to detected γδT-cell cytotoxicity against SH-SY5Y and CHLA-255 cells in presence of α-CD155. (O-Q) IFN-γ, perforin and granzyme B expression are detected by FACS upon PMA and ionomycin stimulation after rhCD155 pre-treatment (left) and MFI is labeled in the representative FACS histograms (right). (R-T) CCK-8, Transwell and wound-healing sassays are performed using SK-N-BE2-NC and SK-N-BE2-KoCD155 cells. Representative images of SK-N-BE2 cell migration obtained from the Transwell (magnification × 100) and wound-healing (magnification × 100) assays are shown (right). The cell numbers obtained from the Transwell assays are counted, and the relative migration rate obtained from the wound-healing assays is calculated by dividing the change in the distance between the scratch edges by the initial distance (left). (U) The phosphorylation of Akt and ERK1/2 in γδT cells is detected by Western blot after SK-N-BE2-NC and SK-N-BE2-KoCD155 stimulation. (V) TIGIT is detected by FACS after 24 h co-culture with SK-N-BE2-NC and SK-N-BE2-KoCD155 cells (left) and MFI is labeled in the representative FACS histograms (right). The results are expressed as the means ± SEMs from at least three independent experiments. Significant differences between groups are represented by ns no significance, * p < 0.05, ** p < 0.01 and *** p < 0.001.

  • Open Access

    Supplementary Tables from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Tables and Supplementary Figure legends

  • Open Access

    Supplementary Figure 2 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 2 Gating strategies of FACS analysis and the expression pattern of TIGIT in NB. (A) Gating strategies for the FACS analysis of circulating γδT cells. (B) Gating strategies for the FACS analysis of tumor infiltrating immune cells. (C) and (D) The expression analysis of CD96 and CD112R in peripheral blood (PB) γδT cells from healthy controls (HC, n = 10) and neuroblastoma patients (NB, n = 18). The proportions of γδT cells are shown in the left panel statistically and the representative FACS histograms are shown in the right panel with mean fluorescence intensity (MFI) labeled in corresponding histograms. (E) Using GSE49711 from GEO database and R2: Genomics Analysis and Visualization Platform, the expression pattern of TIGIT in NB tumors (n = 498) with different INSS stages, risks, MYCN status and death events is analyzed and illustrated by box plots. (F) The overall and eventfree survival curves are generated by grouping samples with the median of TIGIT expression. (G) The expression correlation between TIGIT and DNAM-1 are analyzed using GSE49711 dataset. The results are expressed as the means ± SEMs. Significant differences between groups are represented by ns no significance, ** p < 0.01 and **** p < 0.0001.

  • Open Access

    Supplementary Figure 5 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 5 The expression of CD112 and CD155 in tumor and para-tumor tissue sections detected by immunohistochemistry.

  • Open Access

    Supplementary Figure 9 from Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor–Ligand Interactions That Instructs Intratumoral γδT-cell Activity

    by Xiaolin Wang, Hui Wang, Zhengjing Lu, Xiangjun Liu, Wenjia Chai, Wei Wang, Jun Feng, Shen Yang, Wei Yang, Haiyan Cheng, et al.

    Supplementary Figure 9 The characteristics of NB tumors and immune cells in CD112/CD155 high-ratio and low-ratio groups revealed by bulk RNA sequencing analysis. (A) A total of 3537 DEGs between CD112/CD155 high-ratio and low-ratio groups (grouping according to the ratio median in the violin plot) are identified by RNA sequencing analysis with 38 NB tumor samples and illustrated in volcano plot. (B) The expression of genes related with neuroblastoma in KEGG pathway transcriptional misregulation in cancer is illustrated in heatmap. (C) and (D) The enriched top 20 KEGG pathways in high-ratio or low-ratio tumors are shown in dot plots. (E) and (F) The enriched top 30 GO pathways (top 10 in BP, CC and MF respectively) in high-ratio or low-ratio tumors are shown in dot plots. (G) and (H) The representative GSEA pathways enriched in high-ratio or low-ratio tumors are labeled with NES and p values.